Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose

Clinical and Experimental Allergy

Volumn 31, Issue 9, 2001, Pages 1432-1440

  Kassel, O ^a   De Blay, F ^b   Duvernelle, C ^a   Olgart, C ^a   Israel Biet, D ^c   Krieger, P ^d   Moreau, L ^a   Muller, C ^b   Pauli, G ^c   Frossard, N ^a  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c Hopital Laennec   (France)

^d CNRS   (France)

Author keywords

Airway; Allergy; Asthma; Bronchial biopsy; Bronchoalveolar lavage; Bronchus; Mast cell; Neurotrophin; NGF; Tryptase

Indexed keywords

ALLERGEN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PLACEBO; TRYPTASE;

ARTICLE; ASTHMA; BRONCHUS; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CELL COUNT; CELL GROWTH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EXPOSURE; HUMAN; HUMAN CELL; LUNG LAVAGE; MAST CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ADMINISTRATION, INHALATION; ALLERGENS; ANIMALS; ASTHMA; BIOPSY; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MAST CELLS; NERVE GROWTH FACTOR; RECEPTOR, TRKA; RNA, MESSENGER;

EID: 0034846885     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01177.x     Document Type: Article

References (47)

1. Inflammatory cells in the airways in mild asthma
2. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation
3. Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate
4. Airway mucosal inflammation even in patients with newly diagnosed asthma
5. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects
6. IL-4, IL-5, and IL-6 and tumor necrosis factor-alpha in normal and asthmatic airways - Evidence for the human mast cell as a source of these cytokines
7. Cellular events in the bronchi in mild asthma and after bronchial provocation
8. Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen
9. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways
10. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects
11. New insights into 'The riddle of mast cells': Microenvironmental regulation of mast cell development and phenotypic heterogeneity
12. Development of human mast cells from their progenitors
13. Cytokines involved in growth and differentiation of human basophils and mast cells
14. The nerve growth factor 35 years later
15. Mast cell increase in tissues in neo-natal rats injected with the nerve growth factor
16. Schistosoma mansoni infection enhances the levels of NGF in the liver and hypothalamus of mice
17. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells
18. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor
19. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cells
20. Effect of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells. (HMC-1)
21. Effects of nerve growth factor on rat peritoneal mast cells - Survival promotion and immediate-early gene induction
22. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor
23. Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion
24. Human mast cells express functional TrkA and are a source of nerve growth factor
25. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma
26. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation
27. Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels
28. Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation
29. No signs of activity markers in peripheral blood despite increased bronchial reactivity after repeated low-dose allergen exposure
30. Repeated aerosol exposure to small doses of allergen. A model for chronic allergic asthma
31. Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor SCF by human lung fibroblasts in culture
32. Human bronchial smooth muscle cells in culture produce stem cell factor
33. Cellular and mediator responses twenty-four hours after local endobronchial allergen challenge of asthmatic airways
34. Stem cell factor-induced airway hyperreactivity in allergic and normal mice
35. Increased numbers of circulating basophil progenitors in atopic patients
36. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors
37. + hemopoietic progenitor cells in atopic subjects
38. Allergic rhinitis nasal mucosal conditioned medium stimulates growth and differentiation of basophil/mast cell and eosinophil progenitors from atopic blood
39. Release of nerve growth factor from human airway epithelial cells
40. Human lung fibroblasts secrete nerve growth factor: Effect of inflammatory cytokines and gluco-corticoids
41. Nerve growth factor production by lymphocytes
42. Mast cells synthesize, store, and release nerve growth factor
43. Nerve growth factor is preformed in and activates human peripheral blood eosinophils
44. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma
45. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs
46. Human placental mast cells as an in vitro model system in aspects of neuro-immunotoxicity
47. Cyclooxygenase-2-dependent prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: Its augmentation by extracellular type II secretory phospholipase A2